Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    March 2024
  1. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    PubMed    


  2. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    PubMed     Abstract available


  3. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    PubMed     Abstract available


  4. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    PubMed     Abstract available


    February 2024
  5. GODET C, Brun AL, Couturaud F, Laurent F, et al
    CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
    Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  6. DAMARAJU V, Adimulam GR
    The Conundrum of TB vs Sarcoidosis.
    Chest. 2024;165:e57-e58.
    PubMed    


  7. SHARMA A, Sharma A, Soubani AO
    Epidemiology of COVID 19-Associated Mucormycosis in the United States.
    Chest. 2024;165:307-312.
    PubMed    


  8. IM Y, Kim SY, Kim DH, Jhun BW, et al
    Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.
    Chest. 2024;165:288-302.
    PubMed     Abstract available


    January 2024
  9. TAJIMA Y, Tashiro T, Furukawa T, Murata K, et al
    Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis.
    Chest. 2024;165:e1-e4.
    PubMed     Abstract available


    November 2023
  10. LOEBINGER MR, Quint JK, van der Laan R, Obradovic M, et al
    Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.
    Chest. 2023;164:1115-1124.
    PubMed     Abstract available


  11. KIM JY, Park J, Choi Y, Kim TS, et al
    Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2023;164:1108-1114.
    PubMed     Abstract available


  12. COSTE A, Conrad A, Porcher R, Poiree S, et al
    Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.
    Chest. 2023;164:1097-1107.
    PubMed     Abstract available


    October 2023
  13. SIEGEL SAR, Griffith DE, Philley JV, Brown-Elliott BA, et al
    Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
    Chest. 2023;164:846-859.
    PubMed     Abstract available


    September 2023
  14. LU LY, Lee HM, Burke A, Li Bassi G, et al
    Prevalence, Risk factors, Clinical features, and Outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in Critically Ill Patients: a systematic review and meta-analysis.
    Chest. 2023 Sep 22:S0012-3692(23)05541-1. doi: 10.1016/j.chest.2023.
    PubMed    


  15. OSAWA T, Watanabe M, Morimoto K, Yoshiyama T, et al
    AHL score for predicting mortality risk in patients with pulmonary tuberculosis.
    Chest. 2023 Sep 17:S0012-3692(23)05434-X. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  16. PARDESHI G, Mave V, Gaikwad S, Kadam D, et al
    Glycated Haemoglobin Trajectories and their Association with Treatment Outcomes among Pulmonary Tuberculosis Cases in India - A Prospective Cohort Study.
    Chest. 2023 Sep 4:S0012-3692(23)05377-1. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  17. HESSELS LM, Speksnijder E, Paternotte N, van Huisstede A, et al
    Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.
    Chest. 2023;164:596-605.
    PubMed     Abstract available


    August 2023
  18. VIDYASAGARAN AL, Readshaw A, Boeckmann M, Jarde A, et al
    Is tobacco use associated with risk of recurrence and mortality among people with tuberculosis? A systematic review and meta-analysis.
    Chest. 2023 Aug 29:S0012-3692(23)05372-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


    July 2023
  19. JUNG MK, Lee SY, Min EJ, Ko JM, et al
    CT Differences of Pulmonary Tuberculosis According to Presence of Pleural Effusion.
    Chest. 2023 Jul 7:S0012-3692(23)00953-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  20. COOPER R, Williams M, Fennelly KP
    Abandon the Acid-Fast Bacilli Smear for Patients With TB on Effective Treatment.
    Chest. 2023;164:21-23.
    PubMed    


  21. HENKLE E, Quittner AL, Dieckmann NF, Franklin H, et al
    Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2023;164:53-64.
    PubMed     Abstract available


  22. NAKAYAMA I, Izawa J, Gibo K, Murakami S, et al
    Contamination of Blood Cultures From Arterial Catheters and Peripheral Venipuncture in Critically Ill Patients: A Prospective Multicenter Diagnostic Study.
    Chest. 2023;164:90-100.
    PubMed     Abstract available


    April 2023
  23. FERIOLI M, Ferrari M, Galasso T, Natali F, et al
    A 60-Year-Old Man With a Migratory Lobar Consolidation After Invasive Ventilation.
    Chest. 2023;163:e163-e166.
    PubMed     Abstract available


  24. KIM JY, Lee HW, Yim JJ, Kwak N, et al
    Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis.
    Chest. 2023;163:763-777.
    PubMed     Abstract available


    March 2023
  25. PEREA L, Faner R, Solarat B, Shoemark A, et al
    Low salivary secretory leukocyte protease inhibitor levels are related to airway Pseudomonas aeruginosa infection in Bronchiectasis.
    Chest. 2023 Mar 8:S0012-3692(23)00318-5. doi: 10.1016/j.chest.2023.
    PubMed    


    February 2023
  26. GRAMEGNA A, Narayana JK, Amati F, Stainer A, et al
    Microbial inflammatory networks in bronchiectasis exacerbators with Pseudomonas aeruginosa.
    Chest. 2023 Feb 16:S0012-3692(23)00259-3. doi: 10.1016/j.chest.2023.
    PubMed    


  27. YAN M, Brode SK, Marras TK
    The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
    Chest. 2023;163:281-291.
    PubMed     Abstract available


    January 2023
  28. WONG C, Martinez-Garcia MA
    Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?
    Chest. 2023;163:3-5.
    PubMed    


    November 2022
  29. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    PubMed    


  30. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    PubMed    


  31. LEE S, Lee HW, Kim HJ, Kim DK, et al
    Deep Learning-Based Prediction Model Using Radiography in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:995-1005.
    PubMed     Abstract available


    October 2022
  32. PAN SW, Shu CC
    Time to Consider Treatment Initiation for Patients With Nontuberculous Mycobacterial Lung Disease.
    Chest. 2022;162:e203-e204.
    PubMed    


  33. HENDERSON K, Bilancia R, Choo-Kang B, Maclay J, et al
    An Unusual Case of Postpartum Empyema.
    Chest. 2022;162:e157-e159.
    PubMed     Abstract available


    September 2022
  34. DESHMUKH S, Sane M, Gaikwad S, Sahasrabudhe T, et al
    Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in India.
    Chest. 2022 Sep 26. pii: S0012-3692(22)03893-4. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  35. KIM Y, Yoon JH, Ryu J, Yang B, et al
    Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease.
    Chest. 2022 Sep 7. pii: S0012-3692(22)03704-7. doi: 10.1016/j.chest.2022.08.2228
    PubMed     Abstract available


    August 2022
  36. BLANC PD, Balmes JR, Redlich C
    Occupational Exposures in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:e106-e107.
    PubMed    


    July 2022
  37. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  38. BARKER H, Chen C
    Pandemic Outbreaks and the Language of Violence: Discussing the Origins of the Black Death and COVID-19.
    Chest. 2022;162:196-201.
    PubMed     Abstract available


  39. GREEN HD, Jones AM
    Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series.
    Chest. 2022;162:66-75.
    PubMed     Abstract available


  40. HENRIETTE ZWEIJPFENNING SM, Chiron R, Essink S, Schildkraut J, et al
    Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
    Chest. 2022;162:76-81.
    PubMed    


    May 2022
  41. CHOTIRMALL SH, Aliberti S
    Leveraging the Omics Revolution for Nontuberculous Mycobacteria Biomarkers.
    Chest. 2022;161:1129-1131.
    PubMed    


  42. IM Y, Hwang NY, Kim K, Kim H, et al
    Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.
    Chest. 2022;161:1192-1200.
    PubMed     Abstract available


  43. PARK JW, Curtis JR, Jun KI, Kim TM, et al
    Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.
    Chest. 2022;161:1201-1210.
    PubMed     Abstract available


    April 2022
  44. MA X, Yu D, Jie B, Li LL, et al
    Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined with Pulmonary Tuberculosis.
    Chest. 2022 Apr 28. pii: S0012-3692(22)00880-7. doi: 10.1016/j.chest.2022.
    PubMed    


  45. JUNG HI, Kim SA, Kim HJ, Yim JJ, et al
    Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study in South Korea.
    Chest. 2022;161:918-926.
    PubMed     Abstract available


    March 2022
  46. KUMAR K, Loebinger MR
    Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series.
    Chest. 2022;161:637-646.
    PubMed     Abstract available


    February 2022
  47. LAU A, Lin C, Barrie J, Winter C, et al
    THE RADIOGRAPHIC AND MYCOBACTERIOLOGIC CORRELATES OF SUBCLINICAL PULMONARY TUBERCULOSIS IN CANADA: A RETROSPECTIVE COHORT STUDY.
    Chest. 2022 Feb 2. pii: S0012-3692(22)00214-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  48. DANHO R, Schildkraut JA, Zweijpfenning SMH, Svensson EM, et al
    Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2022;161:370-372.
    PubMed    


  49. KU JH, Siegel SAR, Philley J, Schipper P, et al
    Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States.
    Chest. 2022;161:365-369.
    PubMed    


    January 2022
  50. MELCHERS M, Festen B, den Dekker BM, Mooren ERM, et al
    A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest. 2022;161:e5-e11.
    PubMed     Abstract available


  51. GRIFFITH DE, Daley CL
    Introducing the Nontuberculous Mycobacteria Series for CHEST.
    Chest. 2022;161:1-2.
    PubMed    


  52. DOWNEY DG
    POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes.
    Chest. 2022;161:18-20.
    PubMed    


  53. GRIFFITH DE, Daley CL
    Treatment of Mycobacterium abscessus Pulmonary Disease.
    Chest. 2022;161:64-75.
    PubMed     Abstract available


    December 2021
  54. MASKIN LP, Garcia Hernandez MH, Stryjewski ME, Rodriguez PO, et al
    A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules.
    Chest. 2021;160:e639-e643.
    PubMed     Abstract available


  55. TASHIRO H, Takahashi K, Haraguchi T, Jinnouchi K, et al
    A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction.
    Chest. 2021;160:e623-e628.
    PubMed     Abstract available


  56. JONES TPW, Dabbaj S, Mandal I, Cleverley J, et al
    The Blood Neutrophil Count After 1 Month of Treatment Predicts the Radiologic Severity of Lung Disease at Treatment End.
    Chest. 2021;160:2030-2041.
    PubMed     Abstract available


  57. PREVOTS DR, Marras TK, Wang P, Mange KC, et al
    Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2021;160:2042-2050.
    PubMed     Abstract available


    November 2021
  58. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  59. CORREA LF, Fritscher CC, Fritscher RT, da Silva TKB, et al
    Exclusively Tracheobronchial Paracoccidioidomycosis: A Rare Presentation.
    Chest. 2021;160:e499-e501.
    PubMed     Abstract available


  60. ZUPETIC J, Penaloza HF, Bain W, Hulver M, et al
    Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.
    Chest. 2021;160:1624-1633.
    PubMed     Abstract available


    October 2021
  61. THOMAS-RUDDEL D, Schlattmann P, Pletz M, Kurzai O, et al
    Risk factors for invasive candida infection in critically ill patients - a systematic review and meta-analysis.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04112-X. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  62. HERBERTS MB, Johnson TF, Escalante P
    A 70-Year-Old Man With Cough and Recurrent Respiratory Infections.
    Chest. 2021;160:e347-e350.
    PubMed     Abstract available


  63. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed     Abstract available


  64. MUMMADI SR, Stoller JK, Lopez R, Kailasam K, et al
    Epidemiology of Adult Pleural Disease in the United States.
    Chest. 2021;160:1534-1551.
    PubMed     Abstract available


    September 2021
  65. GRIFFITH DE, Thomson R, Flume PA, Aksamit TR, et al
    Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
    Chest. 2021;160:831-842.
    PubMed     Abstract available


    August 2021
  66. SAHA BK, Chong W
    A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
    Chest. 2021;160:e181-e184.
    PubMed     Abstract available


  67. YU Q, Zhang Q, Yu J, Song Y, et al
    A 66-Year-Old Woman With Progressive Dyspnea and Obstructive Pneumonia.
    Chest. 2021;160:e177-e180.
    PubMed     Abstract available


  68. KANG N, Jeon K, Kim H, Kwon OJ, et al
    Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Chest. 2021;160:436-445.
    PubMed     Abstract available


    July 2021
  69. AKSAMIT TR, Marras TK
    Clofazimine Drug Susceptibility Testing for Nontuberculous Mycobacteria: A Call to Arms.
    Chest. 2021;160:e90.
    PubMed    


    June 2021
  70. BARROS AJ, Enfield KB, Kadl A
    Intraarterial Catheter Use Is Associated With Increased Risk of Hospital Onset Bacteremia: A Retrospective Cohort Study.
    Chest. 2021;159:2321-2324.
    PubMed    


  71. GHEYATH B, Akram A, Gong R, Tovar J, et al
    A 70-Year-Old Man With Conspicuous Thigh Pain and ST-Segment Elevations.
    Chest. 2021;159:e403-e407.
    PubMed     Abstract available


  72. HAWES AM, Chou C, Co I
    An 80-Year-Old Man With Persistent Enterococcus faecalis Bacteremia.
    Chest. 2021;159:e377-e380.
    PubMed     Abstract available


  73. WEINGART MF, Li Q, Choi S, Maleki-Fischbach M, et al
    Analysis of Non-TB Mycobacterial Lung Disease in Patients With Primary Sjogren's Syndrome at a Referral Center.
    Chest. 2021;159:2218-2221.
    PubMed    


    May 2021
  74. MCCALLUM GB, Oguoma VM, Versteegh LA, Wilson CA, et al
    Comparison of First Nations and non-First Nations children's profiles with bronchiectasis over two five-year periods from the Northern Territory, Australia.
    Chest. 2021 May 5. pii: S0012-3692(21)00865-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  75. NADA KM, Nishi S, Duarte A
    Pneumonia and Poorly Controlled Diabetes.
    Chest. 2021;159:e343-e347.
    PubMed     Abstract available


  76. ALLGAIER J, Lagu T, Haessler S, Imrey PB, et al
    Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample.
    Chest. 2021;159:1782-1792.
    PubMed     Abstract available


    April 2021
  77. SEHGAL IS, Basumatary NM, Dhooria S, Prasad KT, et al
    A randomized trial of Mycobacterium w in severe presumed Gram-negative sepsis (MIST).
    Chest. 2021 Apr 11. pii: S0012-3692(21)00680-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  78. GRIFFITH DE, Aksamit TR
    Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
    Chest. 2021;159:1372-1381.
    PubMed     Abstract available


    March 2021
  79. RHEDIN S, Lundholm C, Osvald EC, Almqvist C, et al
    Pneumonia in infancy and risk for asthma - the role of familial confounding and pneumococcal vaccination.
    Chest. 2021 Mar 13. pii: S0012-3692(21)00480-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


    February 2021
  80. METERSKY ML, Choate R
    The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients with Bronchiectasis.
    Chest. 2021 Feb 19. pii: S0012-3692(21)00283-X. doi: 10.1016/j.chest.2021.
    PubMed    


    December 2020
  81. YANG B, Ryu J, Kim T, Jo YS, et al
    Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study.
    Chest. 2020 Dec 26. pii: S0012-3692(20)35503-3. doi: 10.1016/j.chest.2020.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.